en · de · es · fr · pt
glossary-desk.peptides7501.com › Data › Mechanism And Preclinical Findings — Complete Guide

Mechanism And Preclinical Findings — Complete Guide

By Editorial Desk · published 2025-11-02 · last reviewed 2025-11-19 · Data

A practical reference on storage stability: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

This page was last updated on 2025-11-19 and is reviewed periodically as new material appears.

Mechanism and Preclinical Findings

SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.

Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.

The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.

Analytical Detection and Storage

Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.

Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.

Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.

Sr9009 at a glance

PropertyValueNotes
Chemical classSynthetic REV-ERB agonistSmall molecule; not a steroid or peptide.
Primary targetsNR1D1 and NR1D2Also known as REV-ERBα and REV-ERBβ.
Studied routesIntraperitoneal in rodentsOral bioavailability in humans is not established.
Human approvalNo approved therapeutic indicationNo recognized clinical use.
Key uncertaintyHuman physiological effectsPreclinical findings may not translate.

Identity, Handling, and Regulation

Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.

Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.

Related pages on this site

Background and Mechanism

Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.

At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.

Background from the literature

== Treatment == Though treatment of the different chronic wound types varies slightly, appropriate treatment seeks to address the problems at the root of chronic wounds, including ischemia, bacterial load, and imbalance of proteases. Periwound skin issues should be assessed and their abatement included in a proposed treatment plan. Various methods exist to ameliorate these problems, including antibiotic and antibacterial use, debridement, irrigation, vacuum-assisted closure, warming, oxygenation, moist wound healing (the term pioneered by George D. Winter), removing mechanical stress, and adding cells or other materials to secrete or enhance levels of healing factors. It is uncertain whether intravenous metronidazole is useful in reducing foul smelling from malignant wounds. There is insufficient evidence to use silver-containing dressings or topical agents for the treatment of infected or contaminated chronic wounds. For infected wounds, the following antibiotics are often used (if organisms are susceptible) as oral therapy due to their high bioavailability and good penetration into soft tissues: ciprofloxacin, clindamycin, minocycline, linezolid, moxifloxacin, and trimethoprim-sulfamethoxazole. The challenge of any treatment is to address as many adverse factors as possible simultaneously, so each of them receives equal attention and does not continue to impede healing as the treatment progresses.

The horticulture industry embraces the production, processing and shipping of and the market for fruits and vegetables. As such it is a sector of agribusiness and industrialized agriculture. Industrialized horticulture sometimes also includes the floriculture industry and production and trade of ornamental plants. Among the most important fruits are:

The second step in the formation of SCOBY is the introduction of different bacteria into the liquid culture to convert the ethanol product of fermentation into organic acids such as acetic acid, which is a type of ethanol metabolism (lactic acid bacteria may also be added, producing lactic acid from lactic acid fermentation on sugars). A possible byproduct of this reaction is cellulose, which serves as the foundation for the SCOBY biofilm. Like yeasts, the species of bacteria chosen as well as culture conditions directly affect both the characteristics of the liquid kombucha product as well as the composition and morphology of the SCOBY pellicle. While there are many species that have the mechanisms necessary to form cellulose such as Acetobacter and Komagataeibacter, Gluconaceobacter are one of the most populous used, residing in 86–99% of both liquid and biofilm cultures. The necessary culturing conditions of these bacteria are similar to that of yeasts, but require more oxygen due to their aerobic nature in oxidizing ethanol to form organic acids. Once the internal conditions of the co-culture are in place, the symbiotic mixture is left to ferment. Certain studies have claimed optimal fermentation time to be 10 days, but the duration can be modified to change the contents of the yield; greater fermentation times correlate with higher levels of organic acids and other amino acids, which can attribute to the sour undertones of some Kombucha.

Sources: en.wikipedia.org

Further detail

Carbon nanotubes can be functionalized to attain desired properties for use in a wide variety of applications. The two main methods of carbon nanotube functionalization are covalent and non-covalent modification. Because of their apparent hydrophobic nature, carbon nanotubes tend to agglomerate, hindering their dispersion in solvents or viscous polymer melts. The resulting nanotube bundles or aggregates reduce the mechanical performance of the final composite. The surface of the carbon nanotubes can be modified to reduce the hydrophobicity and improve interfacial adhesion to a bulk polymer. Chemical routes such as covalent functionalization have been studied extensively, which involves the oxidation of CNTs via strong acids (e.g. sulfuric acid, nitric acid, or a mixture of both) in order to bond the carboxylic groups to the surface of the CNTs as the final product or for further modification by esterification or amination. Free radical grafting is a promising technique among covalent functionalization methods, in which alkyl or aryl peroxides, substituted anilines, and diazonium salts are used as the starting agents. Functionalization can improve CNTs characteristically weak dispersibility in many solvents, such as water - a consequence of their strong intermolecular p–p interactions. This can enhance the processing and manipulation of insoluble CNTs, rendering them useful for synthesizing innovative CNT nanofluids with properties that are tunable for a wide range of applications.

Mixed ligand complexes are common for amino acids. Well known examples include [Co(en)2(glycinate)]2+, where en (ethylenediamine) is a spectator ligand. In the area of organometallic complexes, one example is the half-sandwich complex Cp*Ir(κ3-methionine).

Generally, metals are shiny and dense. They usually have high melting and boiling points due to the strength of the metallic bond, and are often malleable and ductile (easily stretched and shaped) because the atoms can move relative to each other without breaking the metallic bond. They conduct electricity because their electrons are free to move in all three dimensions. Similarly, they conduct heat, which is transferred by the electrons as extra kinetic energy: they move faster. These properties persist in the liquid state, as although the crystal structure is destroyed on melting, the atoms still touch and the metallic bond persists, though it is weakened. Metals tend to be reactive towards nonmetals. Some exceptions can be found to these generalizations: for example, beryllium, chromium, manganese, antimony, bismuth, and uranium are brittle (not an exhaustive list); chromium is extremely hard; gallium, rubidium, caesium, and mercury are liquid at or close to room temperature; and noble metals such as gold are chemically very inert. Nonmetals exhibit different properties. Those forming giant covalent crystals exhibit high melting and boiling points, as it takes considerable energy to overcome the strong covalent bonds. Those forming discrete molecules are held together mostly by dispersion forces, which are more easily overcome; thus they tend to have lower melting and boiling points, and many are liquids or gases at room temperature. Nonmetals are often dull-looking.

According to a study on well-being by Richards, Campania, and Muse-Burke, "mindfulness is considered to be a purposeful state, it may be that those who practice it belief in its importance and value being mindful, so that valuing of self-care activities may influence the intentional component of mindfulness." Akin to surgery, sometimes the body must be further damaged, before it can properly heal Mental health is conventionally defined as a hybrid of the absence of a mental disorder and the presence of well-being. Focus is increasing on preventing mental disorders. Prevention is beginning to appear in mental health strategies, including the 2004 WHO report "Prevention of Mental Disorders", the 2008 EU "Pact for Mental Health" and the 2011 US National Prevention Strategy. Some commentators have argued that a pragmatic and practical approach to mental disorder prevention at work would be to treat it the same way as physical injury prevention. Prevention of a disorder at a young age may significantly decrease the chances that a child will have a disorder later in life, and shall be the most efficient and effective measure from a public health perspective. Prevention may require the regular consultation of a physician for at least twice a year to detect any signs that reveal any mental health concerns. Additionally, social media is becoming a resource for prevention. In 2004, the Mental Health Services Act began to fund marketing initiatives to educate the public on mental health.

Sources: en.wikipedia.org

Supporting material

==== Scanning electron microscope ==== The scanning electron microscope can provide images of an object's surface at high magnification with a resolution on the order of nanometers. A focused beam of energetic electrons is scanned over the sample and electrons that are backscattered or emitted from the sample surface are detected. Images are constructed via measuring the fluctuations of electrons from the sample beam scanning position. This data is useful in determining what process may have been employed in the materials production and to distinguish between materials of differing origins. Measurement of backscattered electrons elucidate the average atomic number of the area being scanned. The emitted, or secondary electrons provide topological information. This is a relatively straight forward technique, however samples must be amenable to being under a vacuum and may require pre-treatment.

Non-steroidal anti-inflammatory drug (NSAID) can compete with loop diuretics for organic ion transporters, thus preventing the diuretic molecules from being secreted into the proximal convoluted tubules. Those with diuretic resistance, cardiorenal syndrome, and severe right ventricular dysfunction may have better response to continuous diuretic infusion. Diuretic dosages is adjusted to produce 3 to 5 litres of urine per day. Thiazide (blockade of sodium-chloride symporter), amiloride (blockade of epithelial sodium channels) and carbonic anhydrase inhibitors (blockade of chloride-bicarbonate exchanger pendrin) has been suggested to complement the action of loop diuretics in resistance cases but limited evidence are available to support their use.

Other factors not directly related to caloric intake and activity levels that are believed to contribute to obesity include air conditioning, the ability to delay gratification, and the thickness of the prefrontal cortex of the brain. Genetics are also believed to be a factor, with a 2018 study stating that the presence of the human gene APOA2 could result in a higher BMI in individuals. Additionally, factors contributing to the probability of obesity can occur even before birth, including maternal behaviors during gestation such as smoking or significant weight gain. The microbiome (population of microbes like bacteria, fungi, and viruses) of a person's gastrointestinal tract can additionally contribute to obesity, and is also modified by it. Lean people and obese people have been shown to have differences in their gut bacteria which affect their metabolism. Body positivity and Fat acceptance are movements that promote a positive view of all body sizes, including morbid obesity - and aim to curb social stigma regarding obesity. The movement has been the subject of significant criticism for ignoring objective scientific studies and putting participants life at risk.

== R == Radial glial cell A type of glial cell present during brain development that serves as a scaffold for migrating neurons and acts as a neural progenitor cell. Rasmussen's encephalitis A rare chronic inflammatory neurological disorder that typically affects one hemisphere of the brain, causing seizures, progressive weakness, and cognitive decline. Receptor potential A change in membrane potential in a sensory receptor cell in response to a stimulus. It may trigger action potentials in sensory neurons. Receptor tyrosine kinase (RTK) A class of receptors involved in cell growth and differentiation. In neuroscience, RTKs mediate responses to neurotrophic factors like BDNF and NGF. Reelin A protein involved in regulating neuronal migration and positioning during brain development. Disruption is associated with lissencephaly and schizophrenia. Reflex A rapid, automatic motor response to a stimulus, often mediated by the spinal cord without conscious brain involvement. Refractory period A brief period following an action potential during which a neuron is less excitable or unable to fire another action potential. Relative refractory period The phase during which a neuron can fire another action potential, but only with a stronger-than-normal stimulus. Follows the absolute refractory period. REM sleep (Rapid Eye Movement sleep) A sleep phase characterized by rapid eye movements, vivid dreams, muscle atonia, and heightened brain activity resembling wakefulness.

Sumner (1887–1955), 1946 Nobel Prize in Chemistry Kenneth S. Suslick (born 1952), professor at the University of Illinois at Urbana–Champaign, known for optoelectronic nose Edwin Sutermeister (1876–1958), American chemist, known for its work on papermaking Theodor Svedberg (1884–1971), 1926 Nobel Prize in Chemistry Joseph Swan (1828–1914), English physicist, chemist and inventor Frédéric Swarts (1866–1940), Belgian chemist, prepared the first chlorofluorocarbon compound Richard Laurence Millington Synge (1914–1994), 1952 Nobel Prize in Chemistry

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.

How does SR9009 differ from typical receptor agonists?

REV-ERB receptors generally repress transcription when bound by natural heme. SR9009 is described as an agonist that enhances this repressive activity. The result is altered expression of clock and metabolic genes.

Has SR9009 been tested in humans?

Published controlled human trials are lacking. Some sources cite limited or unofficial reports, but these do not establish safety or efficacy. Claims about human performance effects remain unverified.

How is SR9009 measured?

Liquid chromatography-tandem mass spectrometry is a common approach. It can detect the parent compound and its metabolites in biological matrices.

Network